Norges Bank’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Norges Bank’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-332,886	Closed	-$17.8M	–	2246
2016 Q1	$17.8M	Sell	332,886 -19,055	-5%	-$1.41M	0.01%	1226
2015 Q4	$39.8M	Buy	351,941 +184,848	+111%	+$20.4M	0.02%	723
2015 Q3	$19.7M	Buy	+167,093	New	+$21.8M	0.01%	1138
2015 Q2	–	Sell	-41,615	Closed	-$2.41M	–	2373
2015 Q1	$2.41M	Hold	41,615	–	–	﹤0.01%	2040
2014 Q4	$1.34M	Buy	+41,615	New	+$1.25M	﹤0.01%	2151

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Norges Bank's ANAC Position: Q2 2016 in Review

Norges Bank sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 332,886 shares — an estimated $17.8M sold.

Norges Bank first reported a position in ANAC in Q4 2014 and held it in 5 quarters. The position peaked at $39.8M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Norges Bank reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Norges Bank sold 332,886 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $17.8M.
Norges Bank first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 5 quarters.
Norges Bank's ANACOR PHARMACEUTICALS INC COM position peaked at $39.8M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Norges Bank's 13F filing for Q2 2016, filed 12 Aug 2016.